Hearing News Watch

Audiologists are invited to attend a professional education webinar hosted by Dr. David Eagleman, PhD, neuroscientist at Stanford & host of the top-five science podcast: “Inner Cosmos”. Titled “The Neosensory Advantage: Redefining Treatment for Tinnitus and Hearing Loss,” this webinar will explore the latest research on bimodal stimulation and sensory substitution as innovative treatment approaches. Webinar Offering CEU Credit Scheduled

WASHINGTON, D.C. – The American Cochlear Implant Alliance (ACI Alliance) will bestow its prestigious 2024 Lifetime Achievement Award upon Dr. Jill B. Firszt at the upcoming CI2024 Vancouver conference. The Lifetime Achievement Award recognizes an individual’s contributions over their entire career, highlighting their work and accomplishments. Dr. Firszt, an audiologist and researcher, holds positions as a Professor in the Department

SOMERSET, NEW JERSEY – For the 16th consecutive year, Oticon Government Services participated in the Joint Defense Veterans Audiology Conference (JDVAC), the annual meeting of the Association of VA Audiologists and the Military Audiology Association. The three-day conference provides opportunities for networking and collaboration between audiologists treating active-duty service members and those working with Veterans. In a pre-conference training session, Oticon

Plural Publishing has announced the release of a groundbreaking book tailored for audiologists seeking to expand their expertise into the realm of legal proceedings. Titled “Forensic Audiology: A Guide for the Expert Witness,” this comprehensive guide offers invaluable insights into navigating the complexities of forensic audiology within the legal system. Recognizing the gap between audiological knowledge and legal procedure, the

by Terry Mactaggart, President and CEO, Summus Hearing  The case for extending the reach of hearing health services continues to build. Credible research summarizes country and, occasionally, continental status. Global updates are also in. Universally these studies underscore the extent of the public hearing health problem, the mounting costs it creates and, occasionally, ways in which it could be alleviated.

Is it really less expensive to purchase on-premise software than to pay for a monthly subscription? For your average hearing care business with two offices, the price of two Noah System site licenses may be roughly the equivalent to a 4-year Noah ES subscription for three users. However, this figure doesn’t tell the whole story. Initial software price is just

EDEN PRAIRIE, MINNESOTA – Starkey has announced that its Chief Audiology Officer and Executive Vice President of Product Strategy, Dr. Sara Burdak, has been named the Gold Winner for Woman of the Year in the manufacturing category of the Stevie Awards for Women in Business. This global award program recognizes women executives for their innovative initiatives and outstanding leadership. “Receiving this

Pathways, in collaboration with the University of Kentucky Department of Otolaryngology – Head and Neck Surgery, is pleased to announce a virtual mini-symposium focusing on Central Auditory Processing Disorder (CAPD) and Neuroaudiology. The event will take place on Saturday, April 27, 2024 This unique event brings together renowned clinicians and researchers to delve into contemporary topics in these specialized fields.

With hearing loss representing a growing yet vastly undertreated global health crisis, a new webinar looks to combat widespread misconceptions and stigma that discourage people from seeking help. The online event titled “Hearing Loss Misconceptions and Breaking Stigma” is being hosted by Tuned, a digital hearing health company providing preventive and comprehensive hearing health for employers. It will feature insights

MONTPELLIER, FRANCE — Biotechnology company Sensorion has announced that it has met the primary endpoint for its Phase 2a clinical trial of SENS-401, a drug candidate aimed at preserving residual hearing after cochlear implantation. The Phase 2a trial was a multicenter, randomized, controlled, open-label study designed to evaluate the presence of SENS-401 in the inner ear fluid (perilymph) at potentially